Pregnancy and the postpartum period represent phases of heightened vulnerability to
thrombotic microangiopathies (TMAs), as evidenced by distinct patterns of pregnancy …

Accurate assessment of renal histopathology is crucial for the clinical management of
patients with lupus nephritis (LN). However, the current classification system has poor …

Like the majority of renal histopathologic classifications, the 2004 International Society of
Nephrology/Renal Pathology Society (ISN/RPS) classification of lupus nephritis …

Background: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by
the development of autoantibodies and the impairment of the coagulation system …

Objective To develop the second evidence-based Brazilian Society of Rheumatology
consensus for diagnosis and treatment of lupus nephritis (LN). Methods Two methodologists …

Introduction Proliferative lupus nephritis (LN) progresses to end-stage kidney disease
(ESKD) in roughly 10% of the cases despite treatment. Other than achieving< 0.8 g/24h …

Thrombotic microangiopathies (TMA) are usually associated with hematological features
(RH-TMA). The epidemiology of TMA limited to kidneys (RL-TMA) is unclear Therefore …

Introduction Lupus nephritis (LN) may present with thrombotic microangiopathy (TMA) on
kidney biopsy, the impact of which on outcomes is unclear. This study examined the …

De novo thrombotic microangiopathy (TMA) is a rare and challenging condition in kidney
transplant recipients, with limited research on its incidence and impact on graft survival. This …

Background and hypothesis Brazil has the largest number of individuals of African descent
outside Africa and a very admixed population. Among cases of lupus nephritis (LN) in the …